These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 15073856
1. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y. Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856 [Abstract] [Full Text] [Related]
2. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts. García JF, Villuendas R, Sánchez-Beato M, Sánchez-Aguilera A, Sánchez L, Prieto I, Piris MA. Am J Pathol; 2002 Feb 15; 160(2):569-78. PubMed ID: 11839577 [Abstract] [Full Text] [Related]
3. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. Wang YC, Lin RK, Tan YH, Chen JT, Chen CY, Wang YC. J Clin Oncol; 2005 Jan 01; 23(1):154-64. PubMed ID: 15625370 [Abstract] [Full Text] [Related]
4. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding. Stürzenhofecker B, Schlott T, Quentin T, Kube D, Jung W, Trümper L. Leuk Lymphoma; 2003 Sep 01; 44(9):1587-96. PubMed ID: 14565663 [Abstract] [Full Text] [Related]
5. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B, Gazzeri S, Brambilla C, Brambilla E. Oncogene; 2002 Apr 18; 21(17):2750-61. PubMed ID: 11965548 [Abstract] [Full Text] [Related]
6. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma]. Yu GZ, Zhu MH, Ni CR, Li FM, Zheng JM, Gong ZJ. Zhonghua Bing Li Xue Za Zhi; 2004 Apr 18; 33(2):130-4. PubMed ID: 15132849 [Abstract] [Full Text] [Related]
9. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy. Martínez JC, Palomino JC, Cabello A, Sepúlveda JM, de la Cámara AG, Ricoy JR. Histopathology; 2005 Feb 18; 46(2):184-94. PubMed ID: 15693891 [Abstract] [Full Text] [Related]
11. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC. Clin Cancer Res; 2004 Jul 15; 10(14):4734-41. PubMed ID: 15269146 [Abstract] [Full Text] [Related]
12. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordón-Cardó C, van Zee KJ. Breast Cancer Res Treat; 2001 Feb 15; 65(3):225-32. PubMed ID: 11336244 [Abstract] [Full Text] [Related]
13. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C. Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835 [Abstract] [Full Text] [Related]
14. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. Masuya D, Huang C, Liu D, Nakashima T, Yokomise H, Ueno M, Nakashima N, Sumitomo S. J Pathol; 2006 Apr 25; 208(5):724-32. PubMed ID: 16450335 [Abstract] [Full Text] [Related]
15. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Günther T, Schneider-Stock R, Häckel C, Kasper HU, Pross M, Hackelsberger A, Lippert H, Roessner A. Mod Pathol; 2000 Jun 25; 13(6):621-6. PubMed ID: 10874665 [Abstract] [Full Text] [Related]
16. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. Wei WL, Hu HY, Zhang LJ, Chen Y, Ye E, Wang XF. Zhonghua Bing Li Xue Za Zhi; 2011 Aug 25; 40(8):532-6. PubMed ID: 22169642 [Abstract] [Full Text] [Related]
17. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Gorgoulis VG, Zacharatos P, Mariatos G, Liloglou T, Kokotas S, Kastrinakis N, Kotsinas A, Athanasiou A, Foukas P, Zoumpourlis V, Kletsas D, Ikonomopoulos J, Asimacopoulos PJ, Kittas C, Field JK. Cancer Res; 2001 Jan 15; 61(2):538-49. PubMed ID: 11212247 [Abstract] [Full Text] [Related]
18. Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Gorgoulis VG, Zacharatos P, Kotsinas A, Mariatos G, Liloglou T, Vogiatzi T, Foukas P, Rassidakis G, Garinis G, Ioannides T, Zoumpourlis V, Bramis J, Michail PO, Asimacopoulos PJ, Field JK, Kittas C. Mol Med; 2000 Mar 15; 6(3):208-37. PubMed ID: 10965496 [Abstract] [Full Text] [Related]
19. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma. Gorgoulis VG, Rassidakis GZ, Karameris AM, Papastamatiou H, Trigidou R, Veslemes M, Rassidakis AN, Kittas C. Mod Pathol; 1996 May 15; 9(5):544-54. PubMed ID: 8733770 [Abstract] [Full Text] [Related]
20. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H. Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]